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Modulation of protein function is used to intervene
in cellular processes but is often done indirectly by
means of introducing DNA or mRNA encoding the
effector protein. Thus far, direct intracellular delivery
of proteins has remained challenging. We developed
a method termed iTOP, for induced transduction
by osmocytosis and propanebetaine, in which a
combination of NaCl hypertonicity-inducedmacropi-
nocytosis and a transduction compound (propane-
betaine) induces the highly efficient transduction of
proteins into a wide variety of primary cells. We
demonstrate that iTOP is a useful tool in systems in
which transient cell manipulation drives permanent
cellular changes. As an example, we demonstrate
that iTOP can mediate the delivery of recombinant
Cas9 protein and short guide RNA, driving efficient
gene targeting in a non-integrative manner.INTRODUCTION
Modulation of protein function is a powerful means of inter-
vention in disease. Protein manipulation is usually achieved
indirectly, at the DNA or RNA level, either by ‘‘knockdown’’ or
mutation of the encoding gene or by ectopic overexpression of
wild-type or mutant genes. Transient, non-integrative modula-
tion of cell function by direct intracellular delivery of proteins
has appealing application, both in research and the clinic. How-
ever, the currently available toolset for the intracellular transduc-
tion of proteins is limited.
In 1982, Okada and Rechsteiner reported that brief hypertonic
shock followed by a hypotonic treatment can induce the intra-
cellular uptake of proteins into cells (Okada and Rechsteiner,
1982). Unfortunately, this technique proved limited to immortal-
ized cell lines and yielded poor protein transduction efficiencies
and poor cell survival in primary cells. The discovery of cell-
penetrating peptides (CPPs) sparked renewed interest in pro-
tein-mediated cell manipulation. Independent discoveries from
Green and Frankel demonstrated that the HIV TAT protein can674 Cell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc.transduce itself across the cell membrane (Schwarze et al.,
2000). Nagahara and colleagues subsequently demonstrated
that TAT-peptide-mediated protein transduction also worked
when the TAT peptide was cloned as an in-frame fusion to a
recombinant protein of interest, providing a tractable method
for the transduction of recombinant proteins (Schwarze et al.,
2000). CPP-mediated protein transduction appears to work
with all cell types, but the dependence of physical fusion of the
CPP with the cargo protein can disrupt protein function or alter
the subcellular localization of the fusion protein (Lundberg and
Johansson, 2001). Thus, the success of CPP-driven protein
transduction is variable and dependent on the nature and phys-
ical properties of the protein cargo.
Here, we describe a method for the efficient delivery of native
proteins and other macromolecules, such as small RNAs, into
primary cells. We discovered that a combination of small mole-
cules drives the highly efficient intracellular delivery of native
proteins, independent of any transduction peptide. We termed
this process ‘‘iTOP’’ for induced transduction by osmocytosis
and propanebetaine. iTOP is an active uptake mechanism in
which an NaCl-mediated hyperosmolality, in combination with
a transduction compound (a propanebetaine), triggers macropi-
nocytotic uptake and intracellular release of extracellularly
applied macromolecules. We demonstrate that iTOP allows
the highly efficient delivery of recombinant cytoplasmic and
nuclear proteins into a wide variety of primary cell types. Finally,
we demonstrate that iTOP of recombinant Cas9 protein and
in-vitro-transcribed short guide RNA provides a highly efficient
and non-integrative means of gene editing.RESULTS
Transduction of Native Protein Independent
of a Cell-Penetrating Peptide
Protein transduction provides an attractive means to transiently
manipulate cell behavior without risk of permanent changes to
the cell’s genome. We set up a system for protein transduction
into cells by generating recombinant Oct4-VP16 protein with
an N-terminal histidine tag (H6) and a C-terminal poly-arginine
CPP (R11-CPP), to drive self-transduction of the protein across
the cell membrane (Zhou et al., 2006) (Figure 1A). To validate
the system, we also generated recombinant Oct4-VP16 protein
without the R11-CPP or without both the R11-CPP and histidine
purification tags (Figure 1A, top). We used a firefly luciferase re-
porter plasmid containing six tandem Oct4 binding sites (Tomilin
et al., 2000) to measure intracellular activity of transduced Oct4
protein (Figure 1A, bottom). Luciferase activity was measured
12 hr after adding the recombinant Oct4 protein. Transduced
H6-Oct4-VP16-R11 protein activated the Oct4-luciferase re-
porter in a dose-dependent manner (Figure 1B). Surprisingly,
addition of the H6-Oct4-VP16 protein (without R11-CPP) or
Oct4-VP16 protein (without R11-CPP and H6 tag) elicited the
same response (Figure 1B). This finding was highly unexpected,
yet the dose-dependent activation of the Oct4 reporter sug-
gested that Oct4 protein was incorporated into the cells inde-
pendent of the CPP sequence.
We hypothesized that one or more components of the buffer
in which we purified the recombinant protein were responsible
for the CPP-independent protein transduction. To test this, we
examined the effect of omitting individual components of the
buffer on Oct4 transduction. As shown in Figure 1C, Oct4-lucif-
erase reporter activation was abrogated when either NaCl or
non-detergent Sulfobetaine-201 (NDSB-201) was omitted from
the buffer, indicating that a combination of NaCl and NDSB-
201 is required for the introduction of Oct4 protein into cells.
Because omission of either compound could potentially affect
Oct4 protein solubility, it is important to note that the absence
of NaCl or NDSB-201 did not result in Oct4 protein precipitation
from the solution (data not shown). To exclude the possibility that
luciferase reporter activation occurred through an Oct4-protein-
independent manner, we also analyzed the effect of the Oct4
protein on a luciferase reporter without Oct4 binding sites. As
shown in Figure S1A, the Oct4 protein did not activate the lucif-
erase reporter without Oct4 binding sites, demonstrating that
the observed effect was indeed dependent on binding of the
transduced Oct4 protein to the target sites. Oct4 specificity was
further confirmed using a tandem Oct4-Sox2 reporter (Boyer
et al., 2005) and recombinant Oct4 protein synergized with
Sox2, again demonstrating its functional specificity (Figure S1B).
Effect of Osmolality, NDSB-201, Time, and Protein
Concentration
To further examine the protein transduction parameters, we set
up a more direct detection system to quantify transduced
protein. We detected intracellular beta-lactamase, a small
highly soluble protein (Figures S1C and S1D), using CCF2/AM,
a non-fluorescent lipophilic substrate that can readily cross the
cell membrane (Figure 1D, see Experimental Procedures).
Once in the cytosol, CCF2/AM is cleaved by cytosolic esterases,
which activate its fluorescence and leave the now negatively
charged form, CCF2, trapped inside the cell. Upon excitation
at 409 nm, CCF2 emits (green) light at 520 nm. Cleavage of
CCF2 by intracellular beta-lactamase results in a shift in
the emission wavelength to blue (447 nm). Thus, the ratio of
blue versus green signal accurately quantifies intracellular
beta-lactamase.
Using this assay, we explored the effect of time and/or NaCl,
NDSB-201, and protein concentration on protein transduction
of murine embryonic fibroblasts (MEFs). We discovered that
optimal transduction time was directly proportional to thelevel of NaCl-induced hyperosmolality, with higher osmolalities
resulting in faster protein transduction. Figure 1E integrates
the effect of transduction time and different media osmolalities
on beta-lactamase protein transduction. As control, beta-
lactamase was transduced in isotonic media with addition of
NDSB-201 (open squares). At 800 mOsmol/kg, transduction
occurred rapidly (orange line) with optimal transduction time at
1.5 hr. In contrast, at 500 mOsmol/kg, transduction proceeded
slowly, reaching optimal levels after 12 hr (red line). Intermediate
osmolalities resulted in corresponding optimal transduction
times as indicated (red and green lines). Extension of protein
transduction time beyond the optimal timeframewas detrimental
to the cells, resulting in lower transduction efficiency and cell
death (Figure 1E, dashed lines).
We next tested whether other hypertonicity-inducing mole-
cules could mediate protein transduction as well. As shown in
Figure 1F, NaCl, RbCl, KCl, and LiCl all induced protein trans-
duction at varying levels (Figure 1F). In addition, Na-gluconate
supported protein transduction, indicating that the Cl anion
in the added NaCl is dispensable for this process. In contrast,
sucrose-, lactulose-, sorbitol-, and mannitol-induced hyperto-
nicity did not support beta-lactamase protein transduction (Fig-
ure 1F). The above data demonstrate that protein transduction
is critically dependent on hypertonicity induced by alkali metal
cation-containing salts, especially Na+ and Rb+.
Next, we explored the effect of the NDSB-201 concentration
on the beta-lactamase transduction. As shown in Figure 1G,
beta-lactamase transduction was NDSB-201 dependent and
most efficient at an NDSB-201 concentration of 10–25 mM
NSDB-201. At high concentrations, NDSB-201 displays some
toxicity, resulting in a decrease in protein transduction
(Figure S1E).
Finally, we measured CCF2 cleavage as a function of beta-
lactamase concentration. As shown, transduction of increasing
concentrations of beta-lactamase protein for 3 hr in the presence
of 25 mM NSDB-201 and NaCl-adjusted media (osmolality of
700 mOsmol/kg) resulted in increased intracellular beta-lacta-
mase activity (Figure 1H, bars). Beta-lactamase transduction
was not observed in the isotonic controls in the presence of
25 mM NSDB-201 (Figure 1H, open circles).
Altogether, thisdemonstrates that recombinant beta-lactamase
protein is incorporated into the cell and released into the cyto-
plasm and is dependent on hypertonicity induced by Na+- or
Rb+-containing salts, NDSB-201 concentration, transduction
time, and extracellular protein concentration. We termed this
process ‘‘iTOP’’ (induced transduction by osmocytosis and pro-
panebetaine). Accurate determination of the amount of protein
transduced into the cytosol is extremely challenging and is depen-
dent on cell type, protein solubility, half-life, and the concentration
at which it can be applied to the cells. Indeed, Figure 1H demon-
strates a direct relationship between the extracellular concentra-
tion of beta-lactamase protein and the amount transduced into a
cell. To provide a reference for the amount of transduced protein,
we compared iTOP protein transduction to CCP-dependent
protein delivery or the protein transduction method reported
by Okada and colleagues. As shown, iTOP delivery is at least
four times more efficient in transducing protein into primary
fibroblasts than these previously reported methods (Figure S1F).Cell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc. 675
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Figure 1. A Combination of NaCl Hypertonicity and NDSB-201 Induces Transduction of Native Proteins
(A) Top: schematic representation of the Oct4 recombinant proteins used in this study. Bottom: timeline of Oct4 protein transduction assay.
(B) Cos-7 cells were transfected with 6xOct4-TK-Firefly-Luc reporter and, 12 hr later, were transduced with increasing amount of Oct4 proteins as indicated.
Firefly luciferase activity was normalized by co-transfection of Renilla luciferase construct. Controls were cells transduced with an empty or an Oct4-expressing
lentivirus (white and black bars, respectively). Mean ± SD; n = 3.
(C) Cos-7 cells were transfected with 6xOct4-TK-Firefly-Luc reporter and incubated with Oct4-VP16 protein (Oct4 protein in elution buffer, 1:10 diluted in culture
media, black bar) or without protein (white bar). Red bars represent cells transduced with Oct4-VP16 protein in the absence of one of the elution buffer com-
ponents: A: NaCl (1 M), B: NaH2PO4 (50 mM), C: Tris-HCl (50 mM), D: NDSB-201 (250 mM), E: 2-mercaptoethanol (100 mM), F: MgCL2 (125 mM), and ZnCl2
(125 mM). Firefly luciferase activity was normalized with co-transfected Renilla luciferase. Mean ± SD; n = 3.
(D) Schematic representation of the beta-lactamase reporter assay. The cell-permeable CCF2/AM compound is trapped in the cytoplasm by intracellular es-
terases, which convert it to the non-membrane-permeable, fluorescent CCF2. Excitation of CCF2 at 409 nm results in an emission signal at 520 nm (green signal).
CCF2 cleavage by intracellular beta-lactamase abrogates intramolecular FRET, resulting in a shift in the emission wavelength to 447 nm (blue signal).
(legend continued on next page)
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Protective Osmolytes Rescue Hypertonicity-Induced
Cell-Cycle Inhibition
Although the combination of NaCl-induced hyperosmolality and
NDSB-201promotedefficientprotein transduction, it alsoaffected
cell proliferation.Hyperosmotic stress iswell known to inducecell-
cycle arrest, followedbyapoptosis inmammalian cells (Ku¨ltz et al.,
1998). We observed by BrdU incorporation that protein transduc-
tion for 3 hr at 700 mOsmol/kg or for 12 hr at 500 mOsmol/kg
reduces MEF proliferation by more than 60% compared to
untreated cells, independent of the presence of beta-lactamase
(Figure 2A). Apoptosis, measured by caspases 3/7 activity assay,
was not detected in transduced cells (data not shown).
Osmoprotectants (or protective osmolytes) help cells cope
with osmotic stress by accumulating in the cytosol, thereby
balancing theosmotic differencebetween the intra- andextracel-
lular environment. We tested whether the addition of osmopro-
tectants to media would prevent cell-cycle arrest during protein
transduction. MEFs were treated with transduction media alone
or supplemented with different osmoprotectants, and BrdU
incorporation was measured as indicated in Figure 2B. In the
absence of osmoprotectants, incubation of MEFs with transduc-
tionmedia reduced the cell proliferation rate to 34%compared to
non-transduced controls (Figure 2B, red bar). The addition of os-
moprotectants during transduction ameliorated this cell-cycle
arrest to various degrees as shown in Figure 2B (green bars).
The combination of glycerol and glycine was found most
effective and almost completely prevented the hypertonicity-
induced cell-cycle arrest, while still allowing protein transduction
(Figure 2C). Unless otherwise indicated, we therefore included
glycerol and glycine in subsequent protein transduction
experiments.
To explore whether other cell types could similarly be trans-
duced with minimal effect on cell proliferation, we transduced
murine embryonic stem cells (mESCs) with beta-lactamase.
mESCs appeared more sensitive to the hypertonic conditions.
mESC transduction for 3 hr at 700 mOsmol/kg reduced cell
proliferation even with added osmoprotectants glycine and
glycerol (Figure 2D). We therefore examined whether lowering
NaCl-mediated hypertonicity and extending transduction time
(as shown in Figure 1E) would allow transduction of more
sensitive cell types. Indeed, transduction of mESCs for 12 hr at
500 mOsmol/kg resulted in effective beta-lactamase transduc-
tion and minimal effect on cell proliferation (Figure 2D). In fact,
it was possible to perform two subsequent rounds of beta-
lactamase transduction with BrdU incorporation values of 75%
compared to untreated cells (Figure 2E). Thus, a combination
of NaCl-mediated hypertonicity, NDSB-201, glycine, and glyc-(E) MEFs were transduced with 1 mM of beta-lactamase protein, 25 mM NDSB-2
varying amounts of time as indicated. Isotonicmedia (open rhombs) containing NS
a negative control. Relative beta-lactamase activity calculated per well is plotted
death due to prolonged transduction conditions. Mean ± SD, n = 4.
(F) Analysis of the transduction activity of different hypertonicity inducers. MEFs
700 mOsmol/kg induced by different compounds as indicated (red bars, transd
NDSB-201). Relative beta-lactamase protein uptake in isotonic transduction me
(G) Beta-lactamase reporter assay onMEFs transduced for 3 hr with 1 mMof beta-
of 700 mOsmol/kg induced by NaCl (red bars). The controls were cells treated a
(H) Beta-lactamase reporter assay on MEFs transduced as in (G) with different
treated as before in isotonic media (white circles). Mean ± SD; n = 3.erol allows the transduction of native proteins with minimal effect
on cell proliferation.
Efficient Protein Transduction in Multiple Primary
Cell Types
To determine iTOP efficiency and the range of cell types that
could be transduced using this method, we transduced Cre re-
combinase protein in mESC and other primary cells. We used
mESCs containing a single copy of a Cre-activatable GFP-fluo-
rescent reporter integrated in the Rosa26 locus (Srinivas et al.,
2001). As outlined in Figure 3A, Cre-mediated removal of a
loxP-flanked stop cassette activates a GFP reporter, allowing
assessment of the percentage of successfully transduced cells
in a population. mESCs were transduced with Cre protein at
500 mOsmol/kg for 12 hr. Increasing concentrations of recombi-
nant Cre-protein resulted in increased percentage of GFP-
positive (GFP+) cells (Figure 3B). One round of transduction
with 10 mM of Cre protein activated the GFP reporter in 51%
of the mESCs and increased to 79% after a second round of
transduction (Figure 3B). To confirm that protein transduction
did not affect mESC function, we tested the ability of transduced
mESCs to form chimeras upon injection into recipient blastocyst
embryos. Figure 3C shows an image of one of the chimeric mice,
demonstrating that Cre protein transduction does not affect
mESC pluripotency. Chimeric mice were able to generate
offspring, demonstrating that Cre-transduced mESCs contrib-
uted to the germline (Figure 3D).
We next explored Cre recombinase protein transduction in
multiple murine primary cell types isolated from mice carrying
one copy of a lox-mRFP-lox-mGFP reporter. Single Cre protein
transduction for 12 hr at 500 mOsmol/kg efficiently activated
the GFP reporter in multiple cell types, including neuronal and
gut stem cells, dendritic cells, embryonic fibroblasts, glia cells,
and neurons (Figure 3E). The above experiments demonstrate
a highly efficient protein transduction method that is applicable
to many primary cell types.
We also explored whether human embryonic stem cells
(hESCs) could be transduced using this method. We used
H1 hESCs stably transduced with a lentiviral Cre-activatable
reporter containing an active red fluorescence protein (RFP)
gene flanked with LoxP sites, followed by a stop sequence and
a (inactive) GFP reporter gene (Figure 3F). Cre-mediated deletion
of the loxP-flanked RFP-stop segment activates the GFP
reporter. The H1 reporter hESC line was transduced with Cre
protein for 12 hr at 500 mOsmol/kg. As shown in Figure 3G,
we obtained 64% and 78% of GFP-positive cells after one and
two rounds of Cre protein transduction, respectively.01 at different NaCl-adjusted osmolalities (indicated by the color lines) and for
DB-201 and beta-lactamase protein, but without additional NaCl, were used as
as a function of transduction time. Dotted lines indicate the presence of cell
were transduced for 3 hr with 1 mM beta-lactamase protein at an osmolality of
uction with NDSB-201; open circles, control transduction in the absence of
dia (bar #1) was set at 1. Mean ± SD; n = 3.
lactamase protein with different concentrations of NDSB-201with an osmolality
s before but with isotonic media (white circles). Mean ± SD; n = 3.
concentrations of beta-lactamase protein (red bars). The controls were cells
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Figure 2. Addition of Osmoprotectants to the Transduction Media Ameliorates Hypertonicity-Induced Cell-Cycle Inhibition
(A) Beta-lactamase assay (red bars) coupled with BrdU incorporation assay (green squares). MEFs were transduced with 25 mM NDSB-201 at different
osmolalities and time points with or without beta-lactamase as indicated. Beta-lactamase activity was measured relative to cells incubated in isotonic media,
which were set at 1. Cell proliferation was measured by BrdU incorporation as described in the methods. BrdU incorporation of untreated cells was set at 100%
(not shown). Mean ± SD; n = 3.
(B) MEFs were incubated with transduction media, containing 1 mM of beta-lactamase protein, 50 mM of NDSB-201, and an osmolality induced by NaCl of
500 mOsmol/kg (red bar) or with transduction media supplemented with different osmoprotectants as indicated (green bars). The BrdU incorporation
values of untreated cells (left black bar) were set at 100%. BrdU incorporation values of mitomycin-C-treated cells used as control for cell-cycle arrest were
set at 0%. Mean ± SD; n = 3.
(C) Beta-lactamase transduction (red bars) and BrdU incorporation (green squares) in MEFs. Cells were transduced with 25 mM NDSB-201 at different
osmolalities and time points with or without Beta-lactamase as indicated with addiction of 30 mM of glycerol and 15 mM of glycine as osmoprotectants.
Beta-lactamase activity was measured relative to cells incubated in isotonic media, which were set at 1. The BrdU incorporation values of untreated cells and
mytomycin-C-treated cells were set at 100% and 0%, respectively (not shown). Mean ± SD; n = 3.
(D) Beta-lactamase transduction (red bars) and BrdU incorporation (green squares) in mESCs as in (C). Mean ± SD; n = 3.
(E) Beta-lactamase transduction (red bars) and BrdU incorporation (green squares) in mESCs after one or two rounds of protein transduction. mESCs were
transduced once or twice as indicated with a 12 hr interval between transductions. The relative beta-lactamase activity was measured in relation to cells
incubated in isotonic media, which were set at 1. The BrdU incorporation values of untreated cells and mytomycin C treated cells were set at 100% and 0%,
respectively (not shown). Mean ± SD; n = 3.Essential Structural Features of the Transduction
Compound
As shown, the small-molecule NDSB-201 is essential for the
introduction of native protein into cells. NDSB-201 is part of a678 Cell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc.group of zwitterionic compounds used to reduce protein aggre-
gation and facilitate protein refolding (Vuillard et al., 1995). Six
different NDSBmolecules are commercially available (Figure 4A).
To determine the essential chemical properties of NDSB-201,
we analyzed the transduction activity of these NDSBs and their
effect on cell survival. As described before, MEFs were trans-
duced with beta-lactamase protein for 3 hr with NaCl-adjusted
osmolality of 700mOsmol/kg. Beta-lactamase protein transduc-
tion of NDSB-201 (reference molecule #01) was set as 100%.
As shown in Figure 4A, all NDSB molecules were capable of
transducing beta-lactamase protein but with varying efficiencies
and impact on cell proliferation. Whereasmolecules #02 and #03
performed similar or better than our reference compound,
molecules #04 and #06 lowered beta-lactamase transduction
levels and reduced cell proliferation rate; molecule #05 per-
formed poorly and arrested cell cycle, even in the presence of
osmoprotectants.
It is well known that the sulfonate group is a potential cause of
small-molecule toxicity. Thus, we replaced the sulfonate group
in molecules #01 and #03 with a carboxyl group (generating
molecules #09 and #10, Figure 4B) and tested the effect on
transduction and cell proliferation. As shown in Figure 4B,
replacement of the suphonate group did not affect protein
transduction efficiency but further improved cell proliferation,
reaching values of 95% of BrdU incorporation compared to
non-transduced controls.
Further reducing the complexity of compound #09 yielded
compound #11, in which the permanently positively charged
quaternary amine group of compound #09 was replaced by a
primary amine. The resulting molecule is gamma-amino-butyric
acid (GABA), which exists as a zwitterion at neutral pH and
thus contains a similar positive and negative charge at the
molecule’s termini. As shown in Figure 4B, GABA yielded excel-
lent protein transduction efficiency and minimal effect on cell
proliferation, with BrdU incorporation rate of 95% compared to
untransduced controls. The finding that GABA, a well-known
neurotransmitter, can mediate protein transduction was unex-
pected and suggested the involvement of GABA signaling in
this process. However, protein transduction was not affected
byneither the addition ofwell-knownGABAagonists (FigureS2A)
nor specific inhibitors of GABA receptor signaling (Figure S2B).
Moreover, the concentration at which GABA is effective in pro-
tein transduction (25 mM) is similar to the concentration of
NDSB-201 and is about 10,000-fold higher than its EC50 as a
neurotransmitter (±2.5 mM; Mortensen et al., 2010). Therefore,
it seemed likely that the physicochemical properties of GABA,
rather than its role as a signaling molecule, were responsible
for its protein-transducing activity. As mentioned above, the
non-detergent sulfobetaine (NDSB) compoundswere developed
for their ability to enhance protein solubility (Vuillard et al., 1995).
We therefore tested whether GABA could similarly prevent pro-
tein aggregation. A particularly insoluble protein is Cas9, an
RNA-guided nuclease that can be used for specific gene editing,
which we will describe in more detail below. Production and
purification of recombinant Cas9 protein proved particularly
challenging and required a higher concentration of NDSB-201
to prevent the protein aggregation and precipitation. To test
whether GABA was similarly able to promote protein solubility,
we made a dilution series of either NDSB-201 or GABA and
added recombinant Cas9 protein at a final concentration of
10 mM. NDSB-201 efficiently prevented protein precipitation
at a concentration of 200 mM. As shown, GABA could substituteNDSB-201 and prevent protein aggregation at similar concen-
trations (Figure 4C).
At neutral pH, NDSBs and its analogs (Figure 4) are zwitterionic
compounds that have a negatively charged hydrophilic group,
a short 3-carbon hydrophobic chain and a positively charged
amine terminus with various possible substituents. The hydro-
phobic middle domain is too short to form micelles, and thus,
NDSBs are not considered detergents (Vuillard et al., 1995).
To identify the minimal essential structure necessary for trans-
duction, we tested the beta-lactamase protein transduction ac-
tivity of several analogs of NDSB and/or GABA (Figure 4D). We
analyzed the importance of the charged amine and sulfonate/
carboxyl termini of the molecules by removing these groups
from the structure. The analogs lacking the amine (#07 and
#12, Figure 4D) or the sulfonate/carboxyl groups (#08 and #13,
Figure 4D) yielded very poor protein transduction levels and
reduced cell proliferation, although cell survival and beta-lacta-
mase protein solubility were not affected (data not shown).
These data demonstrate that the presence of the amine and sul-
fonate/carboxyl groups at the transduction compound termini is
essential for protein transduction. Finally, we evaluated the
optimal distance between the amine and sulfonate/carboxyl
groups by varying the length of the carbon chain in molecules
#10 and #11 (Figure 4E). As shown in Figure 4E, a deleterious
effect on protein transduction was observed when the carbon
chain was shorter or longer than three carbons. Above data
demonstrate that the minimal structure necessary to allow effi-
cient protein transduction is a zwitterionic molecule, which, at
neutral pH, consists of a positively charged amino group and a
negatively charged sulfonyl or carboxyl group separated by a
three-carbon chain. To assure that the reduced transduction
efficiencies observed by some of the compounds were not the
result of poor protein solubility, we analyzed beta-lactamase
protein precipitation in the presence of different betaine com-
pounds. With the exception of the control sample, in which pro-
tein precipitation was induced by adding ethanol, the different
transduction compounds mentioned above did not induce
beta-lactamase protein precipitation (Figure S2C).
Dissecting the Mechanism of Protein Transduction
Because proteins are too large to diffuse through the plasma
membrane, we suspected that protein transduction involved
an active transport mechanism. Extracellular particles can enter
via several distinct endocytic pathways: dynamin-dependent
endocytosis, which is further subdivided in clathrin- and caveo-
lae-mediated endocytosis, and dynamin-independent endocy-
tosis, which includes macropinocytosis, the uptake of large
(0.5–5 mm) vesicles containing gulps of extracellular fluid. We
used specific inhibitors of these endocytic pathways to deter-
mine the mechanism of protein uptake. MEFs were incubated
with inhibitors of dynamin-, clathrin-, or caveolin-mediated
endocytosis or macropinocytosis for 1 hr prior to transduction
with beta-lactamase protein. As shown in Figure 5A, inhibition
of dynamin-, clathrin-, or caveolin-mediated endocytosis did
not affect beta-lactamase uptake. In contrast, the macropinocy-
tosis inhibitors 5-(N-Ethyl-N-isopropyl)amiloride (EIPA) and
5-(N,N-Dimethyl)amiloride (DMA) resulted in a profound reduc-
tion in beta-lactamase transduction. Macropinocytosis requiresCell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc. 679
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active rearrangements of the actin cytoskeleton, which is
mediated by the small GTPases Rac1 and CDC42 through acti-
vation of the downstream effector kinase Pak1. As expected,
cytochalasin D or latrunculin A, which potently block actin
polymerization, inhibited beta-lactamase transduction (Fig-
ure 5A). In addition, specific inhibitors of RAC1, CDC42, and
Pak1 alone or in combination efficiently block beta-lactamase
transduction in MEFs (Figures S3A and S3B). Altogether, these
results indicate that protein transduction is mediated through
macropinocytosis.
Macropinocytosis is regulated by a family of Na+/H+ antiport-
ers, which are targeted by the EIPA and DMA inhibitors
described above. These NHE antiporters are rapidly activated
in response to a wide variety of extracellular stimuli, including
hypertonicity induced by Na+-containing salts. Nhe1 (Slc9A1)
is a ubiquitously expressed member of this family and therefore
is a likely candidate to be involved in the protein transduction
process. To determine the role of Nhe1 in protein transduction,
we analyzed beta-lactamase protein transduction in Nhe1
mutant MEFs. Heterozygous or homozygous deletion of Nhe1
resulted in a profound reduction in intracellular beta-lactamase
activity, demonstrating that Nhe1 plays an important role in pro-
tein transduction (Figure 5B). The residual protein transduction
activity observed in the absence of Nhe1 function is likely a
redundant effect of other members of the Nhe antiporter family.
Several growth factor activators of tyrosine kinase signaling
were shown to stimulate macropinocytosis. Therefore, we
examined whether the addition of growth factors could enhance
intracellular delivery of beta-lactamase protein. As shown in
Figure 5C, EGF, bFGF, PDGF, IGF, and insulin all enhanced
beta-lactamase transduction, and combinations demonstrated
an additive effect.
The above data demonstrate that iTOP protein transduction
occurs through macropinocytosis uptake of extracellularlyFigure 3. Efficient Cre Protein Transduction in Multiple Primary Stem a
(A) Schematic representation of the Cre reporter inmESCs. A single copy of a loxP
cassette by Cre-recombinase protein induces GFP expression.
(B) Left: FACS analysis of a dose response curve of mESCs transduced with Cre
transduction (panel 5). Right: fluorescence microscopy image of mESCs treated w
the border of each colony. Scale bar, 50 mm.
(C) Left: schematic representation of the mouse chimera assay. mESCs were injec
is assessed by coat color. Cre-protein transduced GFP-positive mESCs derived
host blastocyst (black hear color). Brown hair in the resultant pups indicates chim
(D) Left: schematic representation of the germline transmission assay. Chimera
demonstrates the ESC origin of the germ cells. Center: image of litter with two a
FACS analysis of GFP expression in blood cells of the pups depicted in the centra
pups (#1 and #2) are negative.
(E) Left and middle: Cre protein transduction of multiple cells types derived from l
contrast images of Cre transduced cells. The control was cells incubated with tr
positive cells was determined by flow cytometry. Right top: fluorescence microsc
transduction media without Cre protein. Left: GFP expression. Middle: expression
fluorescence microscopy images of Cre transduced neural cells derived from lox
media without Cre protein. Left: GFP expression. Middle: expression of TuJ1, a
(F) Schematic representation of the Cre recombinase reporter. A lentiviral EF1a-lox
excises the loxP-flanked RFP-STOP cassette and switches fluorescence from re
(G) Left: fluorescence and phase contrast images of Cre-transduced human ESC
was cells incubated with transduction media without Cre protein. Left row, RFP e
50 mm. Right: flow cytometry analysis of Cre-transduced human ESCs. The dens
(lower right area). Double-positive cells (upper right area) result frommultiple integ
in the histogram plots.applied protein, which is subsequently released from the inter-
nalized macropinosomes. To quantify the differential roles of
NaCl hypertonicity and the transduction compound in protein
uptake and intracellular release, we set up two imaging-based
assays.
Macropinocytosis can be quantified by measuring the uptake
of fluorescently labeled high-molecular-weight dextran (Fig-
ure 5D; Commisso et al., 2014). To determine whether dextran
carbohydrate uptake and protein uptake followed the same
path, MEFs were co-transduced with red fluorescent dextran
(TMR-dextran) and far-red fluorescent BSA protein (BSA-
Alexa647) for 1 hr at 700 mOsmol/kg. As shown in Figure 5D,
all dextran-positive macropinosomes contained BSA and vice-
versa, demonstrating that the uptake of TMR-dextran and pro-
teins proceed via the same mechanism (Figure 5D). Moreover,
the simultaneous uptake of Dextran and BSA was blocked by
the macropinocytosis inhibitor EIPA (Figure 5D). Together, these
data demonstrate that the recently described TMR-dextran
assay for the quantification of macropinocytosis (Commisso
et al., 2014) can be utilized to accurately monitor the macropino-
cytotic uptake step in the iTOP process.
To quantify the release of internalized macropinosomes, we
used a galectin3-fluorescent reporter system that has been
described earlier to monitor vesicle leakage induced by drugs
or pathogens (Paz et al., 2010; Ray et al., 2010). Galectin-3 is a
small soluble cytosolic protein that can bind betagalactoside
sugar-containing carbohydrates. These are normally present
only on the exterior of the plasma membrane and the interior of
intracellular endocytic vesicles. Rupture of internalized vesicles
results in galectin-3 relocalization and accumulation at the inter-
nal vesicle membrane. Fusion of galectin-3 to a monomeric
green fluorescent protein (mAG-GAL3) allows visualization of
galectin-3 relocalization and has been used as a tool to monitor
vesicle rupture during pathogen infection (Paz et al., 2010; Raynd Differentiated Cells
-Stop-loxP-GFP reporter was inserted in the Rosa26 locus. Excision of the Stop
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of GFAP, a glia-specific marker. Right: merge. Scale bar, 50 mm. Right bottom:
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et al., 2010). Upon mAG-GAL3 binding to carbohydrates in the
interior of ruptured vesicles, a multimer complex is formed with
intense green fluorescence (Figure 5E). Transduction of MEFs
expressing mAG-GAL3 protein for 1–3 hr at 700 mOsmol/kg
resulted in the appearance of bright green vesicles, demon-
strating leakage of the internalized macropinosome membrane
under iTOP conditions. mAG-GAL3 vesicles were not formed
when cells were pre-incubated with macropinocytosis inhibitor
EIPA or under isotonic conditions (Figure 5E). These results
demonstrate that iTOP conditions promote protein uptake
from the extracellular space via macropinocytosis and induce
macropinosome vesicle leakage to release proteins into the
cytosol.
Using the above assays to quantify uptake and release, we
measured beta-lactamase protein transduction, macropinocy-
tosis, and vesicle leakage (Figure 5F). As expected, protein
transduction measured by beta-lactamase assay was only
observed in cells treated with hypertonic media in the presence
of either NDSB-201 or GABA transduction compounds (Fig-
ure 5F, blue bars). Control compounds with a shorter carbon
chain, glycine, and glycine-betaine, did not mediate beta-lacta-
mase transduction even though macropinocytosis was induced
in all hypertonic conditions (Figure 5F, red bars), indicating that
NaCl hypertonic media alone are sufficient to efficiently induce
macropinocytosis. Transduction compound alone, in the
absence of NaCl-mediated hypertonicity, did not induce macro-
pinocytosis (data not shown). The combined data on beta-lacta-
mase transduction and macropinocytosis suggested that the
transduction compounds were responsible for the release of
protein from the internalized macropinosomes. Indeed, the
mAG-GAL3 reporter assay demonstrated that intracellular mac-
ropinosome leakage only occurred in the presence of NDSB-201
or GABA (Figure 5F, green bars). When macropinosome leakage
occurred, the vesicle contents were completely released into theFigure 4. Structure-Activity Analysis of Protein Transduction Compou
(A) Top: chemical structures of tested non-detergent sulfobetaines. Compoun
BrdU incorporation assays using the different transduction compounds as indi
NaCl-adjusted osmolality of 700 mOsmol/kg, 1 mM Beta-lactamase protein, 30
compounds. Beta-lactamase incorporation values of cells treated with transduc
and values of cells treated with isotonic transduction media were set as 0%,
BrdU incorporation by the transduced cells. BrdU incorporation of untransduced c
set at 0%. Mean ± SD; n = 3.
(B) Top: chemical structures transduction compound analogs. First row: tested an
numbers are indicated below the structure. Bottom: beta-lactamase and BrdU in
MEFs were transduced as described in (A). Beta-lactamase activity and BrdU in
(C) Images demonstrating the effect of increasing concentrations of the transducti
increasing transduction compound concentration (mM). Rows are different trans
(D) Top: chemical structures of transduction compounds analogs. Compounds i
shows analogs without amine group. Right column shows analogs without sulfon
Bottom: beta-lactamase and BrdU incorporation assays using the different trans
protein and beta-lactamase activity and BrdU incorporation were analyzed as in
GABA, #11) was set at 100%. Values derived from compounds #07 and #08 were
referred to compound #11. Beta-lactamase activity of cells treated with isotonic tr
as in (A). Mean ± SD; n = 3.
(E) Analysis of the role of the carbon-chain length. Structures are examples of two
length variations of these. Bottom: beta-lactamase and BrdU incorporation as
transduced with beta-lactamase protein, and beta-lactamase activity and BrdU
reference compounds (#10 and #11) was set at 100%. Beta-lactamase activity o
of compound #14 and #15were referred to compound #10. Values derived of com
shown as open circles as in (A). Mean ± SD; n = 3. For more details of the transdcytoplasm (data not shown). Images of the mAG-GAL3 assay on
the various compounds used in Figure 5F are shown in Fig-
ure S3C. The macropinocytosis inhibitor EIPA efficiently blocked
both beta-lactamase protein transduction, macropinocytosis,
and the appearance of mAG-GAL3-positive vesicles. Together,
these data indicate that NaCl hypertonicity induces macropino-
cytosis-mediated uptake of protein from the extracellular space,
whereas NDSB-201 or GABA molecules promote intracellular
macropinosome leakage, allowing the release of the vesicle
content into the cytosol.
Protein-Mediated Gene Editing
The high efficiency of iTOP has appealing application in systems
in which transient cell manipulation can elicit a binary cellular
effect or response. The recently discovered CRISPR-Cas9 sys-
tem consists of the Streptococcus Pyogenes Cas9 nuclease pro-
tein, which is guided to specific genomic loci by a small guide
RNA (sgRNA) (Charpentier and Doudna, 2013). The Cas9
nuclease creates a double-strand break at the target locus,
which, when repaired through non-homologous end joining
(NHEJ), frequently results in genedisruptionby the resulting frame
shift mutation. Due to its elegant simplicity, the CRISPR-Cas9
system has quickly become a popular tool for gene editing. How-
ever, application of this system by means of DNA or RNA trans-
fection is inefficient in primary cells and typically requires marker
selection of transfected cells. We explored whether iTOP of
recombinant Cas9 protein and its guide RNA can offer an alterna-
tive, more efficient means of applying this gene-editing system.
As shown above, Cas9 protein requires high concentrations
of both salt (500 mM NaCl) and the transduction compound
(250 mM) to remain soluble (Figures 4C and S4A). We noticed
that, under this condition, the NSDB-201 transduction com-
pound was toxic to the cells, but GABA was well tolerated
(Figures S4B and S4C). At this tonicity (1,250 mOsm/Kg),nds
d numbers are indicated below the structure. Bottom: beta-lactamase and
cated. MEFs were transduced for 3 hr with transduction media containing a
mM of Glycerol, 15 mM of Glycine, and 25 mM of the indicated transduction
tion media with the reference compound (NDSB-201, #01) were set as 100%,
as described in the Experimental Procedures. Open circles indicate relative
ells was set at 100%, and BrdU incorporation ofmitomycin-C-treated cells was
alogs with sulfonic group. Second row: analogswith carboxy group. Compound
corporation assays using the different transduction compounds as indicated.
corporation values were analyzed as in (A). Mean ± SD; n = 3.
on compounds NSDB-201 or GABA onCas9 protein solubility. From left to right,
duction compounds. Scale bar, 50 mm.
n left columns contain amine and sulfonate or carboxy group. Central column
ate or carboxy group. Compound numbers are indicated below the structure.
duction compounds as indicated. MEFs were transduced with beta-lactamase
(A). Beta-lactamase activity of the reference compounds (NDSB195, #06 and
referred to compound #6. Values derived from compounds #12 and #13 were
ansduction media was set as 0%. BrdU incorporation is shown as open circles
transduction compounds (reference molecules #10 and #11) with carbon-chain
says using the different transduction compounds as indicated. MEFs were
incorporation were analyzed as in (A). Beta-lactamase incorporation of the
f cells treated with isotonic transduction media was set as 0%. Values derived
pound #16, #17, and #18were referred to compound #11. BrdU incorporation is
uction compounds and their analogs, see Table S2.
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transduction occurs within 60–90 min and is extremely efficient,
as shown by the transduction of recombinant Cre protein (Fig-
ures S4D–S4F). Previous reports have demonstrated that hyper-
tonic stress can cause DNA breaks in inactive regions of the
genome (Redon and Bonner, 2011). However, our iTOP trans-
duction conditions include osmoprotectants, which should pre-
vent DNA damage from occurring. We performed a TUNEL (ter-
minal deoxynucleotyl transferase dUTP nick end labeling) assay
to determine the effect of our iTOP hypertonic conditions in the
presence or absence of osmoprotectants. As expected, the
osmoprotectants in the iTOP transduction buffer effectively
prevented hypertonicity-induced DNA damage (Figure S4G). In
addition to the recombinant Cas9 protein, CRISPR/Cas9 gene
editing requires intracellular delivery of sgRNAs. To determine
whether iTOP transduction allows the intracellular delivery of
RNA molecules as well, we analyzed the effect of siRNA trans-
duction in knocking down target GAPDH. As shown in Fig-
ure S4H, iTOP transduction of siRNA resulted in efficient and
specific knockdown of target GAPDH, demonstrating that, in
addition to protein, iTOP transduction can be used for the
delivery of small RNAs as well.
To explore whether recombinant Cas9 protein and guide
RNA could be co-transduced into cells under iTOP conditions
(iTOP-CRISPR/Cas9), we produced recombinant Cas9 protein
and generated sgRNAs by in vitro transcription from DNA
templates (Figure 6A). A reporter in which the presence of an
AAVS1 target sequence produces an out-of-frame non-fluores-
cent dTomato gene was used to monitor the introduction of
recombinant Cas9-sgRNA (Figure 6B). CRISPR-Cas9 targetingFigure 5. Protein Transduction Is Mediated by Macropinocytosis
(A) MEFs were preincubated for 1 hr and transduced for 3 hr in the presence
Clathrin-mediated endocytosis (Pitstop2 and chlorpromazine), Caveolin-mediate
DMA, Dimethylamiloride), or actin polymerization (Cytochalasin D and Latruncu
protein at a NaCl-adjusted osmolality of 700 mOsmol/kg in transduction me
Glycine supplemented with small-molecule inhibitors as indicated. Relative beta-
Mean ± SD; n = 3.
(B) Role of Nhe1 in protein transduction. MEFs derived from wild-type, Nhe1 hete
1 mM beta-lactamase as in (A). Beta-lactamase transduction values of wild-type
cells in isotonic media (Bar #1) was set at 0%. Mean ± SD; n = 3.
(C) The effect of growth factors on beta-lactamase transduction. MEFs were trans
of 700 mOsmol/kg as in (A) in the presence of 20 ng/ml of epidermal growth fact
derived growth factor (PDGF), 20 ng/ml of insulin growth factor (IGF), 2.5 mg/ml of i
of cells in transductionmedia without growth factor (bar #2) were set at 100%, and
at 0%. Open circles indicate relative BrdU incorporation by the transduced c
incorporation of mitomycin-C-treated cells was set at 0%. Mean ± SD; n = 3.
(D) Left: schematic representation of the macropinocytosis quantification. Righ
incorporation of proteins and non-protein molecules, we analyzed macropinoc
protein (cyan) by GFP-expressing MEFs. Merge of red and cyan gives white by ad
25 mM NDSB-201. The macropinocytosis inhibitor, EIPA (ethylisopropylamilorid
Hoecht 33342 (blue). Scale bar, 50 mm.
(E) Left: schematic representation of the mAG-GAL3 reporter assay. Upon init
pinosomes (black vesicles). Intracellular disruption of the macropinosome memb
of cytosolic mAG-GAL3 protein, resulting in a bright fluorescent signal (bright gre
at 700 mOsmol/kg supplemented with 25 mM NDSB-201 with or without the m
negative control. Note that, under transducing conditions (middle), mAG-GAL3 a
(F) Measurement of protein transduction activity, macropinocytosis, and macropi
Cells were incubated with transduction buffer at 700 mOsmol/kg with different
lactamase protein incorporation in MEFs. Beta-lactamase transduction of cells in
levels were measured by TMR dextran incorporation in cells treated as describe
Right: macropinosome leakage was determined by measuring total area of mAGof the AAVS1 sequence results in a frame shift and activates
dTomato fluorescence. KBM7 cells stably expressing the
reporter were transduced with Cas9 protein together with the
corresponding AAVS1 sgRNA. After one round of Cas9-sgRNA
transduction, 30% of reporter KBM7 cells reestablished
dTomato protein expression (Figure 6C). Upon a second round
of Cas9-sgRNA transduction, 56% of the cells became dTomato
positive. Targeting was specific to the AAVS1 sequence
because off-target sgRNAs with two nucleotide substitutions
did not activate the dTomato reporter (Figure 6C). Similar exper-
iments were performed in H1 human embryonic stem cells with
an observed efficiency of 10% and 26% of dTomato-positive
cells after one and two rounds of transduction, respectively
(Figure 6D). The above results demonstrate that iTOP of recom-
binant Cas9 protein and sgRNA allows efficient and specific
gene modification in reporter cells.
To determine the efficiency of the iTOP-CRISPR/Cas9 system,
we targeted an endogenous gene. We chose to target DPH7
(WDR85), a gene that was identified as an essential host factor
for Diphtheria toxin lethality (Carette et al., 2009). Biallelic
deletion of DPH7 renders human cells resistant to Diphtheria
toxin-induced cell death, providing a simple and effective means
of identifying knockout cells and measuring the efficiency of
biallelic gene knockout upon iTOP-CRISPR/Cas9. We used a
near-diploid clone of the KBM7 cells to disrupt the DPH7 gene
(Figure S5A). KBM7 cells were transduced twice with Cas9 pro-
tein, plus one of six different sgRNAs as are indicated in Fig-
ure 7A. Seven days after protein transduction, cells were treated
with diphtheria toxin for 48 hr, after which the number of viableof small-molecule inhibitors of dynamin-mediated endocytosis (Dynasore),
d endocytosis (Nystatin), macropinocytosis (EIPA, Ethylisopropylamiloride and
lin A) as indicated. MEFs were transduced for 3 hr with 1 mM beta-lactamase
dia containing 25 mM of NDSB-201, 30 mM of Glycerol, and 15 mM of
lactamase protein uptake in isotonic transduction media (left bar) was set at 1.
rozygous (+/), and Nhe1 knockout (/) embryos were transduced for 3 hr with
cells (bar #4) were set at 100%, and beta-lactamase transduction of wild-type
duced for 3 hr with 1 mM beta-lactamase protein at a NaCl-adjusted osmolality
or (EGF), 20 ng/ml of basic fibroblast growth factor (FGF), 20 ng/ml of platelet-
nsulin, and combinations of growth factors as indicated. Beta-lactamase values
beta-lactamase values of cells in isotonic transductionmedia (bar #1) were set
ells. BrdU incorporation of untransduced cells was set at 100%, and BrdU
t: to assess whether the transduction buffer would permit the simultaneous
ytosis-mediated uptake of TMR dextran (red) and fluorescently labeled BSA
ditive color mixture. Transduced cells were incubated at 700 mOsmol/kg with
e), inhibits uptake of TMR dextran and BSA protein. Nuclei were stained with
iation of transduction, extracellularly applied protein is taken up into macro-
rane releases the macropinosome content into the cytoplasm and allows entry
en vesicles). Right: mAG-GAL3 cells were incubated with transduction media
acropinocytosis inhibitor EIPA as indicated. Untreated cells were included as
ccumulates in the compromised macropinosomes. Scale bar, 200 mm.
nosome vesicle leakage of NDSB-201 and examples of derivative compounds.
transduction compounds or left untreated, as indicated. Left: relative beta-
isotonic transduction media (black bar) was set at 1. Middle: macropinocytosis
d above, and total area of dextran positive vesicles per cell was determined.
-Gal3-positive vesicles per cell. Mean ± SD; n = 3.
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Figure 6. Gene Editing Using Simultaneous Transduction of Recombinant Cas9 Protein and sgRNA
(A) Top: schematic representation of the in-vitro-transcribed sgRNAs containing 20 nucleotides of guide sequence and 80 nucleotides of scaffold sequence.
Bottom: protein gel of recombinant purified Streptococcus pyogenes Cas9 protein.
(B) Schematic representation of the CRISPR-Cas9 reporter system. Cells were transduced with a lentiviral vector containing the CRISPR-Cas9 target sequence
followed by an out-of-frame sequence of dTomato gene. CRISPR-Cas9 induced DNA double-strand break in the target sequence, followed by NHEJ repair that
inducesDNA deletions and/or insertions. Those DNAmodificationsmay restore the dTomato reading frame, producing red cellular fluorescence. DNA sequences
in red and green represent the ‘‘target sequence,’’ where red and green text represents the ‘‘sgRNA binding’’ sequence and the ‘‘protospacer-adjacent motif,
PAM’’ sequence, respectively.
(C) CRISPR-Cas9 reporter KBM7 cells were transduced with Cas9 protein and target sgRNA. Negative control was cells transduced without Cas9 and sgRNA.
Specificity controls were performed by transducing cells with Cas9 protein and off-target sgRNAs. The percentage of dTomato-positive cells was determined by
flow cytometry analysis. Bottom shows phase contrast and fluorescent images for indicated conditions. Scale bar, 250 mm.
(D) CRISPR-Cas9 reporter H1 human embryonic stem cells were transduced with Cas9 protein and on-target sgRNA. Negative control was cells transduced
without Cas9 and sgRNA. Specificity controls were performed by transducing cells with Cas9 protein and off-target sgRNAs. The percentage of dTomato-
positive cells was determined by flow cytometry analysis. Bottom shows phase contrast and fluorescent images for indicated conditions. Dotted lines delineate
the border of the hES colony. White scale line represents 50 mm.cells was determined. Samples transduced with Cas9 protein
and DPH7 sgRNAs yielded high levels of cell survival, whereas
no viable cells were detected in diphtheria-toxin-treated wild-
type KBM7 cells or in cells transduced with Cas9 protein with
a control sgRNA (Figure 7A). DNA sequence analysis on the
pool of diphtheria-toxin-resistant cells demonstrated DPH7
gene disruption at the sgRNA target site in all resistant cells (Fig-
ures 7B and S5B), confirming that diphtheria toxin resistance
was the result of Cas9-sgRNA targeting. Similar results were
obtained when H1 human ESCs were targeted with recombinant
Cas9 protein coupled to DPH7 sgRNAs (Figure 7C).686 Cell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc.To determine the frequency of biallelic DPH7 gene disruption,
we transduced KBM7 and H1 cells with Cas9 protein and the
corresponding DPH7 sgRNA as described above. Upon trans-
duction, single cells were sorted into 384-well plates (Figure 7D).
After a week, emerging clones were treatedwith diphtheria toxin,
and resistant clones were counted to quantify the percentage of
knockout clones. Four out of six sgRNAs yielded around 70%
resistant clones, which is a remarkable efficiency considering
that diphtheria resistance requires biallelic deletion of DPH7
gene (Figure 7D). Indeed, sequence analysis revealed biallelic
mutations at the sgRNA target sites in all clones analyzed
(Figure 7E, top). Similar results and knockout efficiency were ob-
tained upon transduction of human ESCs (Figure 7E, bottom).
Above results demonstrate the particular strength of the iTOP-
CRISPR/Cas9 system in enabling high-efficiency gene editing
in primary (stem) cells (Figure S5C). DPH7 knockout clones of
hESCs retained expression of essential hESC markers, as well
as the ability to generate derivatives of all three germ layers
in vitro, demonstrating that iTOP-CRISPR/Cas9 gene knockout
did not affect stem cell pluripotency (Figure S6).Conclusions
Despite vast improvement in technologies for the delivery of
DNA or RNA into cells, the manipulation of primary cells often
remains difficult, with low percentages of targeted cells, poor
control over insert copy number, and/or unstable gene expres-
sion levels. The ability to efficiently transduce native proteins
into primary cells offers new opportunities for direct cell manip-
ulation without the need for DNA or RNA intermediates. Proteins
allow cell manipulation in a non-integrative manner and are
particularly suited in binary systems in which a single, transient
cell manipulation results in a permanent change in cell function,
identity, or (epi)genetic state.
The iTOP system described here is highly efficient and flexibly
adaptable. Variation in NaCl hypertonicity, type and concen-
tration of transduction compound, and variation in transduction
time can be fine-tuned to the needs of the user, the specific target
cell type, and the biochemical characteristics of the transduced
protein. Because the amount of transduced protein is directly
related to the extracellular protein concentration, the system
allows narrow dosage of the effective intracellular protein levels.
The CRISPR/Cas9 gene editing has revolutionized our ability
to modulate the genome and development of a safe and efficient
means to apply this technology in primary cells allowing the use
of CRISPR/Cas9 in the modulation of genetic defects. Recent
reports demonstrate that delivery of recombinant Cas9 protein
using CPPs, electroporation, or cationic lipids results in effective
gene editing of immortalized cell lines, but primary cells remain
a challenge (Kim et al., 2014; Ramakrishna et al., 2014; Zuris
et al., 2014). We demonstrate that the iTOP system allows highly
efficient gene modification upon transduction of recombinant
Cas9 protein and in-vitro-transcribed sgRNA (iTOP-CRISPR/
Cas9). The transient nature of iTOP-CRISPR/Cas9 assures
that the transduced gene-editing system does not remain
inside the cell, leaving only the editing event as a permanent
result of the cell manipulation. The high efficiency to knockout
genes using protein iTOP has appealing application in research
and perhaps will allow new therapeutic avenues for the treat-
ment of genetic disease. In addition to gene editing, protein
iTOP may have application in other areas, for example in
the modulation of intracellular signaling pathways, in cell
differentiation/dedifferentiation, or as adjuvants in dendritic cell
immunization.EXPERIMENTAL PROCEDURES
Cell Lines
COS7 cells—ATCC, H1 human ESCs—WiCell, and KBM7 cells were a gift from
Dr. Brummelkamp, NKI Amsterdam.Mouse embryonic neural stem (NSC) cellswere derived from E13.5 mice embryos as described by Louis and Reynolds
(2005). Mouse gut organoids were derived from adult mice as reported by
Sato et al. (2009).
Cell Proliferation Assay
Cell proliferation was determined using the Cell Proliferation ELISA kit, BrdU
(Roche, 11669915001) followingmanufacturer’s instructions. Formore details,
see Supplemental Information.
Transduction Buffer
53 Transduction Buffer
500mMNaCl, 25mMNaH2PO4, 250mMNDSB-201, 150mMglycerol, 75mM
glycine, 1.25 mMMgCl2, 1 mM 2-mercaptoethanol at pH 8.0. For more details,
see Supplemental Information.
CRISPR/Cas9 Transduction Media
Opti-MEM media (Life Technologies) supplemented with 542 mM NaCl,
333 mM GABA, 1.673 N2, 1.673 B27, 1.673 non-essential amino acids,
3.3 mM Glutamine, 167 ng/ml bFGF2, and 84 ng/ml EGF. For more details
on media preparation and catalog numbers, see Supplemental Information.
Recombinant Protein Production
His-tagged recombinant proteins were produced in E. Coli and purified using
Ni-agarose affinity chromatography. Detailed methods and procedures are
described in the Extended Experimental Procedures, as well as Tables S1
and S5.
Protein Transduction
We have established two transduction protocols that work best for most cell
types and proteins to be transduced, typically yielding transduction effi-
ciencies of 60%–90%. In the first protocol, transduction is performed for
12 hr at an osmolality of 500 mOsmol/kg (protocol 12/500). In brief, a day
before protein transduction, cells were plated in the appropriate culture
media without antibiotics. Next day, 53 transduction buffer with the protein
of interest was mixed with cell culture media to obtain 13 transduction media
at a tonicity of 500 mOsmol/kg and added to the cells. Cells were incubated
for 12 hr, after which transduction media were removed and exchanged
for regular culture media. In the second protocol, protein transduction is
performed for 3 hr at an osmolality of 700 mOsmol/kg (protocol 3/700).
Cells were plated as above. The next day, 13 transduction media with
the protein of interest were added as above, and final osmolality was
adjusted to 700 mOsmol/kg using NaCl. Cells were incubated for 3 hr, after
which transduction media were removed and exchanged for regular culture
media.
Beta-Lactamase Transduction and Quantification of Beta-
Lactamase Incorporation
Beta-lactamase transduction in MEFs and mES cells was performed using
the 3/700 and 12/500 protocol, respectively. After protein transduction,
beta-lactamase activity was measured using the CCF2-AM loading kit
(Life Technologies, K1032) following the manufacturer’s instructions. Relative
beta-lactamase activity was calculated using the following formula: relative
beta-lactamase activity (%) = (XB)/(AB)*100, where X represents the
beta-lactamase value of the sample; A is the beta-lactamase value of a
reference sample, and B is the beta-lactamase value of cells transduced
in isotonic media. For more details see Supplemental Information.
CRISPR-Cas9 Transduction
KBM7 cells were transduced with Cas9 protein and sgRNA with transduction
media at 1,250 mOsmol/kg during 60 min in a 96-well format. In brief, 120,000
KBM7 cells were seeded per well using KBM7 media (IMDM supplemented
with 10% FBS, non-essential amino acids, glutamax, 2-mercaptoethanol).
The next day, 3 hr before transduction, cells were incubated 250 ng/ml of the
interferon inhibitor B18R (eBiosciences). Then, cell culture media was removed
andcomplete transductionmixture (10ml ofCas9 in53 transductionbuffer, 30ml
of CRISPR/Cas9 transductionmedia, and10ml of sgRNAsolution)was added to
cells. sgRNA and DNA plasmid sequences are shown in Data S1, Data S2, and
Data S3. Cells were incubated during 60 min at 37C, and the transductionCell 161, 674–690, April 23, 2015 ª2015 Elsevier Inc. 687
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A1-TTTCGCCCTGCAAACGGTGGACACC-----GACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGCA D5
A2-TTTCGCCCTGCAAACGGTGGACACCGAGCTGAACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGC +1
A1-TTTCGCCCTGCAAACGGTGGACACCGAGCTG-CCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGCA D1
A2-TTTCGCCCTGCAAACGGTGGACACCGAGCTGAACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGC +1
A1-TTTCGCCCTGCAAACGGTGGACACCGAGCTGAACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGC +1
A2-TTTCGCCCTGCAAACGGTGGACACCG---------CGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCTGCAGGCA D9/+51
DPH7 sgRNA #2; 15 mutant sequences out of 15 sequences = 100%
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTGACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT WT
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCT-ACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D1
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTG-CCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D1
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTGA-CGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D1
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGC-------GGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D7
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTGAC-------TCGGTGGAGTGGTGCCCGCTGCAAGGCT D7 [4x]
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGA----------ACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D10
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACC------------GACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D12
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTGAC----TCC----TGGAGTGGTGCCCGCTGCAAGGCT D12/+3
ATGATGGGCTGTTTCGCCCTGCAAACGG---------------------ACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D21
ATGATGGGCTGTTT--------------------------------CGGACTCGGTGGAGTGGTGCCCGCTGCAAGGCT D32
ATGATGGGCTGTTTCGCCCTGCAAACGGTGAACACCGAGCTGAACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGC +2
ATGATGGGCTGTTTCGCCCTGCAAACGGTGGACACCGAGCTGAACCGCGGACTCGGTGGAGTGGTGCCCGCTGCAAGGC +1
(legend on next page)
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media was carefully replaced by standard culture media supplemented with
250 ng/ml of B18R. Cells were incubated for 48 hr and analyzed by flow cytom-
etry. Knockout of endogenous DPH7 gene was determined by adding LFn-DT
(Carette et al., 2009) and DNA sequencing of the surviving cells. Two rounds
of Cas9/sgRNA transductionwere performed as abovewith a recovery time be-
tween transductionsof 5–7days.SeeTablesS3andS4 forprimer sequences for
genomic DNA amplification and surveyor assay.
H1 human ESCs were transduced as above with slight modifications.
Cells were passaged by mechanical dissociation into small clumps following
mTeSR1 manufacturer’s instructions and seeded on a matrigel-coated plate.
Cells were transduced 2–3 days after seeding when they reached a confluency
of 80%–90%. Two rounds of Cas9/sgRNA transduction were performed the
same as above with a recovery time between transductions of 5–7 days. Cells
were not passaged between two transductions.
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(A) Top: schematic depiction of theDPH7 gene and target sites of six different sgR
transduction and diphtheria toxin selection procedure. KBM7 cells were transdu
ductions. Controls were untreated cells and cells transduced with Cas9 together a
with LFn-DTA. Bar graph shows the number of viable cells after 2 days of diphth
(B) Analysis of target-site mutations in the endogenous DPH7 gene in diphtheria-
in-vitro-transcribed sgRNA. The wild-type (WT) sequence is shown at the top. St
and yellow background and insertions with underlined green text. The sizes of th
Numbers in brackets show the amount of sequences obtained. In the wild-type se
red and blue text, respectively. The primers used to amplify the different DPH7 g
(C) Analysis of target-site mutations at endogenous DPH7 gene in diphtheria to
in-vitro-transcribed DPH7 sgRNAs. Annotation as in (B).
(D) Schematic representation of the experimental design used for the quantifica
hESCswere transduced once or twice (as indicated) with Cas9 together withDPH
3 days, single cells were sorted into 384-well plates using a flow cytometer. 7 days
diphtheria toxin. After 2 days of diphtheria toxin treatment, surviving clones were
single-cell clones that were diphtheria toxin resistant of total clones obtained.
(E) Biallelic DNA sequence analysis of diphtheria toxin-resistant clones in KBM7 c
insertions (+) or deletions (D) are indicated to the right of each mutated site.N.G. are co-inventors on a patent application describing the transduction
technology PCT/IB2014/064127 and co-founders of NTrans technologies.
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